课题基金 / 基金详情

A novel splicing program that controls cancer cell metastasis

A novel splicing program that controls cancer cell metastasis
控制癌细胞转移的新型剪接程序
批准号:
2873243
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Microbial infections result in the death of over 4 million people/year, with the mortality rate of invasive fungal infections ranging between 40-90%. Despite the prominence, high mortality rates, and limited treatment options for invasive fungal infections, our understanding of fungal virulence is in its infancy compared to bacterial and viral infections. With antifungal resistance on the increase (Candida auris has been declared a global health threat by the WHO due to the emergence of multi-drug resistant strains), there is an urgent need to identify novel antifungal drug targets. To be able to cause infections microbes must compete with the host's innate immune system. The continued arms race between microbes and the immune system has led to pathogens evolving mechanisms to evade and escape the actions of the immune system. To date, we have shown that the opportunistic human fungal pathogen Candida albicans have evolved two innate immune evasion strategies. The first is through the concealment of the highly immunogenic carbohydrate beta-glucan, and the second is through the inhibition of the human alternative complement system. However, recent work in the Hall group has identified a new, as yet to be described, innate immune evasion strategy in C. albicans. The aim of this PhD is to characterise and define the molecular mechanism behind this novel innate immune evasion strategy. Combining the fungal molecular biology, and host-pathogen interaction expertise of the Hall lab with global transcriptomics and proteomics approaches from the Skipp lab, you will identify the host environmental conditions that promote fungal innate immune evasion, identify the key proteins involved in the process, and unravel the regulatory signalling pathways that lead to immune evasion. Therefore, this project will provide expensive training in microbiology, molecular biology, microscopy and immunology techniques, as well as bioinformatic analysis of large data sets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
CircSLTM及其编码多肽SLTM-99aa通过SAFB介导的mRNA剪接重塑在胃癌发生发展中的分子机制及其临床价值研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    胡柯峰
  • 依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
  • 批准号:
    82372743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈卓佳
  • 依托单位:
MEK/ERK通路对Bim选择性剪接的调节及其在胃癌细胞对化疗敏感性中作用
  • 批准号:
    81071809
  • 项目类别:
    面上项目
  • 资助金额:
    33.0万元
  • 批准年份:
    2010
  • 负责人:
    张旭东
  • 依托单位:
c-Abl调控U2AF65介导的mRNA剪接及核质转运机制研究